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Calcium phosphate cements (CPCs) represent feasible synthetic
bone substitution and regeneration materials. To facilitate degra-
dation, composites of CPC and degradable, polymeric micropar-
ticles have been developed. In addition to the creation of porosity
within the implant after microparticle degradation, these micro-
particles can be loaded with appropriate biologicals (e.g. growth
factors) to direct biological responses.
The current study focused on the in vivo effects of injectable
composites consisting of CPC with microspheres, either or not
loaded with transforming growth factor-b1 (TGF-b1). Bone aug-
mentation properties of an injectable CPC/PLGA composite were
evaluated using an in vivo rat model, in which the composite was
injected onto the skull for implantation periods of 2, 4, and 8
weeks. Histological and histomorphometrical analyses showed that
microsphere loading with TGF-b1 signiﬁcantly increased initial
bone-implant contact. Moreover, TGF-b1 loading signiﬁcantly
enhanced bone formation after prolonged implantation periods.
Alternatively, an injectable CPC/gelatin composite was implanted
in a cylindrical femoral condyle defect in rabbits for 4, 8, and 12
weeks. Irrespective of TGF-b1-loading, all implants showed an
increase in mechanical strength with implantation time. Further,
TGF-b1-loading signiﬁcantly accelerated implant degradation,
whereas no effects on bone-implant contact or bone formation
were observed compared to composites containing non-loaded
gelatin microspheres. These results demonstrate the applicability
of CPC/microsphere composites for bone augmentation and sub-
stitution, and demonstrate that growth factor loading of the mi-
crospheres can further direct biological responses.
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The potential immune privilege presented by mesenchymal stem
cells (MSCs) makes them a promising population in tissue engi-
neering and regenerativemedicine. In this study, we investigated the
effect of culture medium (expansion versus osteogenic media) over
the in vivo potential of adult stem cells derived from human bone
marrow (hBMMSCs) and amniotic ﬂuid (hAFSCs).To this end, we
isolated hAFSCs from day 6 supernatant of the cultures of amniotic
ﬂuid obtained from amniocentesis, and hBMMSCs were a kind gift
from Biopredic. Cells were maintained in culture until conﬂuence
either in expansion or in osteogenic media (7 days), and then
transplanted into 58 to 62 day-old foetal sheep at a concentration of
1106 cells/foetus. Pregnant ewes were fasted for 24 hours. General
anaesthesia was induced with thiopental sodium and maintained by
inhalation anaesthesia with isoﬂurane and oxygen. After general
anaesthesia, the ewes were positioned in dorsal recumbency and
prepared in a sterile surgical environment for a ventral midline
celiotomy. The abdomen was exposed through a ventral midline
incision and the gravid uterus located. After the identiﬁcation of
the foetus inside the uterus and their gentle handling contention
against the inner epithelium layer of the uterus, cells were trans-
planted into the intraperitoneal foetus cavity by injection through
the intact uterus walls. The animals were euthanized sixty days after
transplant, and samples from various tissues were collected. The
engraftment and phenotype of human-derived cells was evaluated
by ﬂow cytometry and immunocytochemistry analysis.
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Objective: Our group has previously demonstrated the synthesis of
dynamically-conditioned tissue-engineered heart valves based on
an autologous ﬁbrin scaffold. The present study aims to evaluate
the structure and mechanical stability of ﬁbrin-based heart valves
following implantation in a sheep model.
Methods: Autologous tissue-engineered heart valves were
moulded using a ﬁbrin scaffold, ovine carotid artery-derived
myoﬁbroblasts and endothelial cells, before subjection to 28 days
of mechanical conditioning in a bioreactor. Following condition-
ing, tissue-engineered valves were implanted in the pulmonary
trunk of the same animals (n¼ 4) from which the cells had been
harvested; identical valves conditioned in parallel served as con-
trols. Valves were explanted after 1 and 2 months and analysed
using routine histology, immunohistochemistry, electron micros-
copy (EM) and extracellular matrix (ECM) assay.
Results: Explanted valve conduits had excellent tissue consis-
tency after 2 months in vivo. Routine histology showed excellent
tissue development and cell distribution, functional blood vessel
ingrowth in the conduit wall, with no evidence for inﬂammation.
Immunohistochemistry and ECM assay demonstrated almost
complete resorption of ﬁbrin gel components and replacement with
ECM proteins. A monolayer of vWf-positive endothelial cells
lined the valve surface, and was shown to be completely conﬂuent
using scanning EM. The resident valve tissue cells were in ex-
cellent health, as evidenced by transmission EM.
Conclusions: Preliminary results of implanted ﬁbrin-based tis-
sue engineered heart valves are encouraging, with remarkable
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